ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway

Chen, Xi; Zhu, Mingwei; Zou, Xiaomeng; Mao, Yingxuan; Niu, Jiamei; Jiang, Jian; Dong, Tianxiu; Shi, Ying; Yang, Xiuhua*; Liu, Pengfei*哈尔滨医科大学; 1
Life Sciences2022-12-15DOI: 10.1016/j.lfs.2022.121174
2被引20阅读
引用收藏
分享

摘要

Aims: Glioblastoma (GBM) with aggressive nature and poor prognosis has become the most common intracranial tumor. Most clinical chemotherapeutic drugs fail to achieve the anticipated therapeutic outcome. This study identified the anti-GBM effects of ginkgolic acids (GAs) and elucidated the potential molecular mechanisms, exploiting the significant antitumor effects of GAs, which are widely present in the outer bark of Ginkgo biloba.Materials and methods: Two GBM cell lines, U251 and T98G, were selected for in vitro experiments to evaluate the antitumor effects of GA. Cell viability and proliferation were examined by MTT and colony formation assay. The effect of GA on apoptosis and the cell cycle was examined by flow cytometry. Scratch and Transwell assays reflected the migration and invasion ability. The molecular mechanisms were explored by using immunoblot analysis, RNA sequencing and bioinformatics. In the nude mouse transplantation tumor model, preclinical treatment effects were assessed by ultrasound and MRI. Key findings: The present study showed that GA inhibited the proliferation, migration, invasion, stemness, epithelial-to-mesenchymal transition (EMT) of GBM cells and induced apoptosis by inhibiting CCL2, affecting the JAK-STAT and PI3K-AKT signaling pathways, and inhibiting the EMT regulators Snail and Slug. Finally, GA showed significant control of tumors in a GBM xenograft model. Significance: GA inhibits the progression of GBM cells by targeting CCL2, affecting the JAK-STAT and PI3K-AKT signaling pathways, and inhibiting the EMT regulators Snail and Slug. The outstanding antitumor properties of GA provide a novel strategy for the GBM therapy.

学科与关键词

关键词
GlioblastomaGinkgolic acidCCL2JAK3-STAT1PI3K-AKTSignaling pathway
相关
加载中…
  • Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway
    Xu, Peng; Wang, Handong*; Pan, Hao*; Chen, Jiakai; Deng, ChuleiCancer Chemotherapy and Pharmacology, 2022, 89(2): 183-196.被引 14
  • Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway
    Zhu, Mingwei; Niu, Jiamei; Jiang, Jian; Dong, Tianxiu; Chen, Yaodong; Yang, Xiuhua*; Liu, Pengfei*Life Sciences, 2022, 293: 120358.被引 6
  • VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
    Zheng, Congying; Mao, Chengliang; Tang, Kai; Shu, Hang*Neuropsychiatric Disease and Treatment, 2023, 19: 1397-1408.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Life Sciences
发表日期
2022-12-15
卷期
第 311 卷
页码
121174
DOI
10.1016/j.lfs.2022.121174
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82272053]

作者

  • C

    Chen, Xi (第一作者)

    1 · harbin med univ

  • Z

    Zhu, Mingwei

    1 · harbin med univ

查看全部 10 位作者收起作者
  • Z

    Zou, Xiaomeng

    1 · harbin med univ

  • M

    Mao, Yingxuan

    1 · harbin med univ

  • N

    Niu, Jiamei

    1 · harbin med univ

  • J

    Jiang, Jian

    1 · harbin med univ

  • D

    Dong, Tianxiu

    1 · harbin med univ

  • S

    Shi, Ying

    1 · harbin med univ

  • Y

    Yang, Xiuhua (通讯)

    1 · harbin med univ

  • L

    Liu, Pengfei (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417